Association of prevalence and comorbidities with demographic variation at diagnosis for those living with cancer in London
PHE ePoster Library. Loughran M. 09/12/17; 186455; 198
Molly Loughran
Molly Loughran
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)
Abstract BackgroundApproximately half of those diagnosed with cancer today will live for at least 10 years and will require healthcare support. Comorbidity may impact the effectiveness and delivery of their cancer treatment, survival outcomes, and quality of life. This study explores the variation in comorbidity and demographics at the time of cancer diagnosis in people living in London to understand differing needs.MethodData on people living in London diagnosed with cancer in 1995-2014, still alive on 31/12/14, was extracted from Public Health England's cancer registration system. Comorbidity at diagnosis based on the Charlson Comorbidity Index for those diagnosed in 2007-2014 was derived using cancer registration and Hospital Episode Statistics records. This indicates comorbidities sufficiently serious to warrant inpatient admission. Looking at 27 months to three months prior to diagnosis, qualifying diagnoses were used to produce a weighted score. For patients with multiple tumours, details of their most recent tumour were used. Results are presented grouped by Charlson score stratified by geography, sex, socio-economic deprivation, tumour site, age, and years since diagnosis. ResultsThere were 219,444 people living with cancer diagnosed in 1995-2014, still alive on 31/12/14. Of the 140,613 people diagnosed in 2007-2014, 12% had at least one comorbidity whilst 88% had no serious comorbidities recorded.Variation for those with at least one comorbidity was found by CCG, gender, age, and deprivation.ConclusionThis work provides valuable new intelligence in understanding differing demographics and needs of patients with various levels of comorbidity for those living with and beyond cancer.
Abstract BackgroundApproximately half of those diagnosed with cancer today will live for at least 10 years and will require healthcare support. Comorbidity may impact the effectiveness and delivery of their cancer treatment, survival outcomes, and quality of life. This study explores the variation in comorbidity and demographics at the time of cancer diagnosis in people living in London to understand differing needs.MethodData on people living in London diagnosed with cancer in 1995-2014, still alive on 31/12/14, was extracted from Public Health England's cancer registration system. Comorbidity at diagnosis based on the Charlson Comorbidity Index for those diagnosed in 2007-2014 was derived using cancer registration and Hospital Episode Statistics records. This indicates comorbidities sufficiently serious to warrant inpatient admission. Looking at 27 months to three months prior to diagnosis, qualifying diagnoses were used to produce a weighted score. For patients with multiple tumours, details of their most recent tumour were used. Results are presented grouped by Charlson score stratified by geography, sex, socio-economic deprivation, tumour site, age, and years since diagnosis. ResultsThere were 219,444 people living with cancer diagnosed in 1995-2014, still alive on 31/12/14. Of the 140,613 people diagnosed in 2007-2014, 12% had at least one comorbidity whilst 88% had no serious comorbidities recorded.Variation for those with at least one comorbidity was found by CCG, gender, age, and deprivation.ConclusionThis work provides valuable new intelligence in understanding differing demographics and needs of patients with various levels of comorbidity for those living with and beyond cancer.
    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings